ʻaoʻao_banner

huahana

Lemairamin (WGX-50) mea hana pauka CAS No.: 29946-61-0 98.0% maemae min.no nā mea hoʻohui

ʻO ka wehewehe pōkole:

ʻO ka Lemairamin a i ʻole Wgx50 kahi hui kūlohelohe i unuhi ʻia mai nā pepa chili i hōʻike i nā hopena maikaʻi i ka pale ʻana i ka maʻi o Alzheimer.Ua ʻike nā haʻawina hiki iā ia ke kāohi i ka apoptosis neuronal Aβ-induced, hoʻemi i ka ʻona calcium neuronal, a hoʻemi i ka hōʻiliʻili ʻana o nā oligomers Aβ i ka cerebral cortex.


Huahana Huahana

Huahana Huahana

Nā Kūlana Huahana

Inoa mea kūʻai

Lemairamina

inoa ʻē aʻe

2-Propenamide, N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenyl-, (2E)-;

Lemairamina (WGX-50)

CAS No.

29946-61-0

ʻAno molekala

C19H21NO3

Kaumaha molekula

311.37

Maemae

98.0%

Ka nana aku

ʻO ka pauka keʻokeʻo keʻokeʻo

Palapala noi

Mea ʻai meaʻai kumu

Hoʻolauna huahana

ʻO ka Lemairamin a i ʻole Wgx50 kahi hui kūlohelohe i unuhi ʻia mai nā pepa chili i hōʻike i nā hopena maikaʻi i ka pale ʻana i ka maʻi o Alzheimer.Ua ʻike nā haʻawina hiki iā ia ke kāohi i ka apoptosis neuronal Aβ-induced, hoʻemi i ka ʻona calcium neuronal, a hoʻemi i ka hōʻiliʻili ʻana o nā oligomers Aβ i ka cerebral cortex.Eia hou, ua hōʻike ʻia ka wgx50 e hoʻomaikaʻi i ka hana cognitive i nā ʻiole.Hōʻike ka noiʻi he hiki i ka wgx50 ke pale i ka hui pūmua-protein ma waena o nā moleke amyloid.ʻO ka holoʻokoʻa, hiki i ka wgx50 ke pale i ka maʻi o Alzheimer a hiki ke hāʻawi i nā ala hou no ka hoʻomohala ʻana i nā lāʻau lapaʻau e kuhikuhi ana i nā oligomers Aβ.Hoʻohui ʻia, hōʻike ʻo WGX-50 i ka hana anti-inflammatory koʻikoʻi, e lilo ia i moho hoʻohiki no ka mālama ʻana i nā maʻi ʻeha.Ua ʻike ʻia ʻo WGX-50 i nā hopena koʻikoʻi ma ka ʻili, e like me ka hōʻemi ʻana i nā wrinkles a me ka hoʻomaikaʻi ʻana i ka elasticity ʻili.Ma waho aʻe o nā pūhui kūlohelohe i lawe ʻia mai ka mea kanu Zanthoxylum bungeanum, aia i kēia manawa nā mea hoʻohuihui synthetic i hoʻohana ʻia i nā noi like ʻole a ʻoi aku ka maikaʻi no ka mākeke.

Hiʻona

(1) Maʻemaʻe kiʻekiʻe: Hiki i ka Lemairamin ke loaʻa i nā huahana maʻemaʻe kiʻekiʻe ma o ka ʻili kūlohelohe a me ka hoʻomaʻemaʻe ʻana i nā kaʻina hana.ʻO ka maʻemaʻe kiʻekiʻe, ʻoi aku ka maikaʻi o ka bioavailability a me ka liʻiliʻi o nā hopena ʻino.

(2) Palekana: Palekana kiʻekiʻe, liʻiliʻi nā hopena maikaʻi ʻole, ʻaʻohe hopena maikaʻi ʻole me ka hoʻohana lōʻihi.

(3) Paʻa: He kūpaʻa maikaʻi ka Lemairamin a hiki ke mālama i kāna hana a me ka hopena ma lalo o nā kaiapuni like ʻole a me nā kūlana mālama.

(4) Maʻalahi ke komo: Hiki ke hoʻopili koke ʻia ka Lemairamin e ke kino kanaka a hāʻawi ʻia i nā ʻiʻo a me nā ʻāpana like ʻole.

Nā noi

ʻO Lemairamin kahi pūhui amide i lawe ʻia mai ka ʻili o ka mea kanu Zanthoxylum bungeanum.Hoʻohana ʻia i kēia manawa ma ke ʻano he meaʻai meaʻai, hana pū ia ma ke ʻano he agonist o ka alpha7 nicotinic acetylcholine receptor (α7nAChR), ka mea e hōʻemi ai i ka neuroinflammation i ka maʻi o Alzheimer, a ua synthetic loa. apoptosis, ho'ēmi i ka neuronal calcium toxicity, hoʻemi i ka hōʻiliʻili o Aβ oligomers i loko o ka cerebral cortex, a me ka hoʻomaikaʻi ʻana i ka hana cognitive i nā ʻiole.


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou